nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Clotting—Tretinoin—peripheral nervous system neoplasm	0.0313	0.0451	CcSEcCtD
Fluoxymesterone—Clotting—Isotretinoin—peripheral nervous system neoplasm	0.0313	0.0451	CcSEcCtD
Fluoxymesterone—Blood cholesterol increased—Tretinoin—peripheral nervous system neoplasm	0.0278	0.04	CcSEcCtD
Fluoxymesterone—Blood cholesterol increased—Isotretinoin—peripheral nervous system neoplasm	0.0278	0.04	CcSEcCtD
Fluoxymesterone—Azoospermia—Cisplatin—peripheral nervous system neoplasm	0.0268	0.0386	CcSEcCtD
Fluoxymesterone—PRLR—Prolactin receptor signaling—PTPN11—peripheral nervous system neoplasm	0.0254	0.0873	CbGpPWpGaD
Fluoxymesterone—Clotting—Alitretinoin—peripheral nervous system neoplasm	0.0238	0.0342	CcSEcCtD
Fluoxymesterone—Blood cholesterol increased—Alitretinoin—peripheral nervous system neoplasm	0.0211	0.0303	CcSEcCtD
Fluoxymesterone—Hirsutism—Isotretinoin—peripheral nervous system neoplasm	0.0193	0.0277	CcSEcCtD
Fluoxymesterone—Hirsutism—Tretinoin—peripheral nervous system neoplasm	0.0193	0.0277	CcSEcCtD
Fluoxymesterone—Oligospermia—Epirubicin—peripheral nervous system neoplasm	0.0177	0.0255	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0164	0.0236	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0164	0.0236	CcSEcCtD
Fluoxymesterone—Oligospermia—Doxorubicin—peripheral nervous system neoplasm	0.0164	0.0236	CcSEcCtD
Fluoxymesterone—Hirsutism—Alitretinoin—peripheral nervous system neoplasm	0.0146	0.021	CcSEcCtD
Fluoxymesterone—Coagulopathy—Tretinoin—peripheral nervous system neoplasm	0.0144	0.0207	CcSEcCtD
Fluoxymesterone—Coagulopathy—Isotretinoin—peripheral nervous system neoplasm	0.0144	0.0207	CcSEcCtD
Fluoxymesterone—Azoospermia—Epirubicin—peripheral nervous system neoplasm	0.0138	0.0198	CcSEcCtD
Fluoxymesterone—Azoospermia—Doxorubicin—peripheral nervous system neoplasm	0.0128	0.0183	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Melphalan—peripheral nervous system neoplasm	0.0126	0.0181	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0124	0.0179	CcSEcCtD
Fluoxymesterone—PRLR—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.0118	0.0406	CbGpPWpGaD
Fluoxymesterone—Coagulopathy—Dactinomycin—peripheral nervous system neoplasm	0.0118	0.0169	CcSEcCtD
Fluoxymesterone—Coagulopathy—Alitretinoin—peripheral nervous system neoplasm	0.0109	0.0157	CcSEcCtD
Fluoxymesterone—PRLR—ErbB4 signaling events—ERBB2—peripheral nervous system neoplasm	0.0102	0.035	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.00846	0.0122	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00635	0.0218	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.0057	0.00819	CcSEcCtD
Fluoxymesterone—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.00567	0.00815	CcSEcCtD
Fluoxymesterone—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.00565	0.00813	CcSEcCtD
Fluoxymesterone—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.00565	0.00813	CcSEcCtD
Fluoxymesterone—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00562	0.00808	CcSEcCtD
Fluoxymesterone—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00562	0.00808	CcSEcCtD
Fluoxymesterone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—peripheral nervous system neoplasm	0.00559	0.0192	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.00558	0.00802	CcSEcCtD
Fluoxymesterone—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.00555	0.00798	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—NCAM1—peripheral nervous system neoplasm	0.00553	0.019	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—COX2—peripheral nervous system neoplasm	0.00548	0.0188	CbGpPWpGaD
Fluoxymesterone—Seborrhoeic dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00545	0.00783	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.00542	0.0078	CcSEcCtD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.00528	0.0182	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00518	0.0178	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.00509	0.0175	CbGpPWpGaD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00504	0.00725	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.00501	0.0172	CbGpPWpGaD
Fluoxymesterone—Alopecia—Topotecan—peripheral nervous system neoplasm	0.00501	0.0072	CcSEcCtD
Fluoxymesterone—Alopecia—Isotretinoin—peripheral nervous system neoplasm	0.00497	0.00714	CcSEcCtD
Fluoxymesterone—Alopecia—Tretinoin—peripheral nervous system neoplasm	0.00497	0.00714	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.00497	0.00714	CcSEcCtD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.00492	0.0169	CbGpPWpGaD
Fluoxymesterone—Alopecia—Melphalan—peripheral nervous system neoplasm	0.0049	0.00705	CcSEcCtD
Fluoxymesterone—ESR1—Estrogen signaling pathway—GNAS—peripheral nervous system neoplasm	0.00487	0.0168	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00482	0.0166	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.00434	0.0149	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IFNB1—peripheral nervous system neoplasm	0.00434	0.0149	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00428	0.00616	CcSEcCtD
Fluoxymesterone—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00426	0.00613	CcSEcCtD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.00424	0.0146	CbGpPWpGaD
Fluoxymesterone—Amenorrhoea—Epirubicin—peripheral nervous system neoplasm	0.00422	0.00608	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.00422	0.00608	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.0042	0.0144	CbGpPWpGaD
Fluoxymesterone—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00415	0.00597	CcSEcCtD
Fluoxymesterone—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00415	0.00597	CcSEcCtD
Fluoxymesterone—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.00406	0.00584	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00403	0.00579	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00399	0.00574	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00399	0.00574	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.00398	0.0137	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00394	0.00567	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.00391	0.00562	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00391	0.00562	CcSEcCtD
Fluoxymesterone—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.00376	0.00541	CcSEcCtD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—AKT1—peripheral nervous system neoplasm	0.00365	0.0125	CbGpPWpGaD
Fluoxymesterone—Alopecia—Vincristine—peripheral nervous system neoplasm	0.00363	0.00522	CcSEcCtD
Fluoxymesterone—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.00362	0.262	CrCbGaD
Fluoxymesterone—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00361	0.0052	CcSEcCtD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CHEK2—peripheral nervous system neoplasm	0.0036	0.0124	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00359	0.00516	CcSEcCtD
Fluoxymesterone—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00359	0.00516	CcSEcCtD
Fluoxymesterone—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00354	0.00509	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HGF—peripheral nervous system neoplasm	0.00335	0.0115	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00324	0.0111	CbGpPWpGaD
Fluoxymesterone—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00321	0.00461	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	0.00315	0.0108	CbGpPWpGaD
Fluoxymesterone—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00315	0.00452	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00303	0.00435	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00297	0.00427	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00294	0.00423	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00294	0.00423	CcSEcCtD
Fluoxymesterone—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00294	0.00423	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00292	0.00419	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0029	0.00418	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.00285	0.0098	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00284	0.00976	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.00281	0.00966	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD55—peripheral nervous system neoplasm	0.0028	0.00963	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00278	0.004	CcSEcCtD
Fluoxymesterone—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00272	0.00391	CcSEcCtD
Fluoxymesterone—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00268	0.00386	CcSEcCtD
Fluoxymesterone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00262	0.00377	CcSEcCtD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—BIRC5—peripheral nervous system neoplasm	0.00261	0.00897	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.0026	0.00892	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00258	0.00371	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00258	0.0037	CcSEcCtD
Fluoxymesterone—Headache—Topotecan—peripheral nervous system neoplasm	0.00252	0.00363	CcSEcCtD
Fluoxymesterone—Headache—Tretinoin—peripheral nervous system neoplasm	0.0025	0.0036	CcSEcCtD
Fluoxymesterone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.0025	0.0036	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.00245	0.00842	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—PTPN11—peripheral nervous system neoplasm	0.00244	0.0084	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.00241	0.0083	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0024	0.00346	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	0.00239	0.00823	CbGpPWpGaD
Fluoxymesterone—Nausea—Topotecan—peripheral nervous system neoplasm	0.00239	0.00344	CcSEcCtD
Fluoxymesterone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00237	0.00341	CcSEcCtD
Fluoxymesterone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00237	0.00341	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00236	0.0034	CcSEcCtD
Fluoxymesterone—Nausea—Melphalan—peripheral nervous system neoplasm	0.00234	0.00337	CcSEcCtD
Fluoxymesterone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00232	0.00333	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00223	0.00321	CcSEcCtD
Fluoxymesterone—ESR1—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.00222	0.00763	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.0022	0.00755	CbGpPWpGaD
Fluoxymesterone—Megestrol acetate—ABCB1—peripheral nervous system neoplasm	0.00219	0.159	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00219	0.00752	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.00216	0.00744	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00215	0.00309	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—CD34—peripheral nervous system neoplasm	0.00212	0.0073	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00212	0.00305	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—PPP3R1—peripheral nervous system neoplasm	0.00204	0.00702	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.002	0.00688	CbGpPWpGaD
Fluoxymesterone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00194	0.00279	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0019	0.00273	CcSEcCtD
Fluoxymesterone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.00273	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00189	0.00649	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00188	0.00645	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00187	0.00269	CcSEcCtD
Fluoxymesterone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00186	0.00268	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00183	0.00629	CbGpPWpGaD
Fluoxymesterone—Headache—Vincristine—peripheral nervous system neoplasm	0.00183	0.00263	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00181	0.00623	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NCAM1—peripheral nervous system neoplasm	0.0018	0.0062	CbGpPWpGaD
Fluoxymesterone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.0018	0.00259	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.00175	0.00602	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00174	0.0025	CcSEcCtD
Fluoxymesterone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00249	CcSEcCtD
Fluoxymesterone—Nausea—Vincristine—peripheral nervous system neoplasm	0.00173	0.00249	CcSEcCtD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00173	0.00594	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00172	0.00248	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00168	0.00577	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00168	0.00576	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CDKN2A—peripheral nervous system neoplasm	0.00167	0.00572	CbGpPWpGaD
Fluoxymesterone—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00165	0.00237	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.00155	0.00532	CbGpPWpGaD
Fluoxymesterone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00153	0.0022	CcSEcCtD
Fluoxymesterone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00219	CcSEcCtD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.00152	0.00524	CbGpPWpGaD
Fluoxymesterone—Headache—Etoposide—peripheral nervous system neoplasm	0.00148	0.00213	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	0.00147	0.00505	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00145	0.00497	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00143	0.00492	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IFNB1—peripheral nervous system neoplasm	0.00142	0.00487	CbGpPWpGaD
Fluoxymesterone—Nausea—Etoposide—peripheral nervous system neoplasm	0.0014	0.00202	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00139	0.00478	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00139	0.00477	CbGpPWpGaD
Fluoxymesterone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00138	0.00198	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00136	0.00469	CbGpPWpGaD
Fluoxymesterone—Spironolactone—ABCB1—peripheral nervous system neoplasm	0.00136	0.0988	CrCbGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.00134	0.00462	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—peripheral nervous system neoplasm	0.00134	0.00461	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00132	0.0019	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00132	0.00454	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00132	0.00452	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	0.00132	0.00452	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00129	0.00445	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.00128	0.00441	CbGpPWpGaD
Fluoxymesterone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00183	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00127	0.00437	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.00127	0.00436	CbGpPWpGaD
Fluoxymesterone—Norethindrone—ABCB1—peripheral nervous system neoplasm	0.00127	0.0918	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00176	CcSEcCtD
Fluoxymesterone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00171	CcSEcCtD
Fluoxymesterone—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.00118	0.0858	CrCbGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MYC—peripheral nervous system neoplasm	0.00117	0.00403	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.00117	0.00402	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.00116	0.00399	CbGpPWpGaD
Fluoxymesterone—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.00116	0.0841	CrCbGaD
Fluoxymesterone—ESR1—LKB1 signaling events—MYC—peripheral nervous system neoplasm	0.00115	0.00395	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00115	0.00395	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00114	0.00392	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00113	0.00389	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.00111	0.00383	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00158	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—HGF—peripheral nervous system neoplasm	0.00109	0.00376	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.00109	0.00375	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	0.00107	0.00369	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00107	0.00368	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.00104	0.00357	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00104	0.00356	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000992	0.00341	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EED—peripheral nervous system neoplasm	0.000979	0.00337	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000977	0.00336	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000976	0.0014	CcSEcCtD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	0.000944	0.00325	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000938	0.00323	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	0.000908	0.00312	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000906	0.0656	CrCbGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000903	0.0013	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.000899	0.00309	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000894	0.00307	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000879	0.00302	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000856	0.00294	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000849	0.00292	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.000836	0.00288	CbGpPWpGaD
Fluoxymesterone—Headache—Epirubicin—peripheral nervous system neoplasm	0.00083	0.00119	CcSEcCtD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000828	0.00285	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000809	0.00278	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTPN11—peripheral nervous system neoplasm	0.000798	0.00274	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	0.000797	0.00274	CbGpPWpGaD
Fluoxymesterone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000787	0.00113	CcSEcCtD
Fluoxymesterone—AR—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000783	0.00269	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—peripheral nervous system neoplasm	0.000782	0.00269	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000779	0.00268	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000771	0.00265	CbGpPWpGaD
Fluoxymesterone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000768	0.0011	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000767	0.00264	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EED—peripheral nervous system neoplasm	0.000754	0.00259	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.000748	0.00257	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EED—peripheral nervous system neoplasm	0.000743	0.00255	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000742	0.00255	CbGpPWpGaD
Fluoxymesterone—Progesterone—ABCB1—peripheral nervous system neoplasm	0.000738	0.0535	CrCbGaD
Fluoxymesterone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.00105	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.0007	0.00241	CbGpPWpGaD
Fluoxymesterone—Testosterone—ABCB1—peripheral nervous system neoplasm	0.000698	0.0506	CrCbGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.000693	0.00238	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.000682	0.00235	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000682	0.00234	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.000675	0.0489	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.000639	0.0022	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000639	0.0022	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—peripheral nervous system neoplasm	0.00063	0.00217	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.00063	0.00216	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.000624	0.00214	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000603	0.00207	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000594	0.00204	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	0.000591	0.00203	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.00058	0.00199	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.000579	0.00199	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000578	0.00199	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	0.000555	0.00191	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	0.000553	0.0019	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000546	0.00188	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000539	0.00185	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000517	0.00178	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000516	0.00177	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000511	0.00176	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000492	0.00169	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.00048	0.00165	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—peripheral nervous system neoplasm	0.00048	0.00165	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.000473	0.00163	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	0.000469	0.00161	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000453	0.00156	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	0.00045	0.00155	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000449	0.00154	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000447	0.00154	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000421	0.00145	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000408	0.0014	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000379	0.0013	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000372	0.00128	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00037	0.00127	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000355	0.00122	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—peripheral nervous system neoplasm	0.000351	0.00121	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000349	0.0012	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000346	0.00119	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00034	0.00117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.000329	0.00113	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000314	0.00108	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00031	0.00107	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—peripheral nervous system neoplasm	0.00031	0.00107	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000292	0.001	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.00029	0.000998	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000289	0.000993	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000286	0.000985	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000269	0.000924	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000248	0.000853	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000242	0.000832	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000237	0.000816	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000227	0.00078	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000225	0.000773	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.0002	0.000689	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000186	0.00064	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000173	0.000596	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000171	0.000587	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000159	0.000548	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000152	0.000522	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000139	0.000479	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—peripheral nervous system neoplasm	0.000108	0.000372	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.68e-05	0.000333	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	8.34e-05	0.000287	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—peripheral nervous system neoplasm	8.22e-05	0.000282	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.65e-05	0.000263	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—peripheral nervous system neoplasm	7.51e-05	0.000258	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.95e-05	0.000239	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.82e-05	0.0002	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	5.78e-05	0.000199	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—peripheral nervous system neoplasm	5.7e-05	0.000196	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.42e-05	0.000186	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.45e-05	0.000153	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.26e-05	0.000146	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.76e-05	0.000129	CbGpPWpGaD
